A cat can look completely fine at eleven years old and still be in the early stages of kidney disease. That is not an edge ...

A Johns Hopkins retrospective cohort study found 96% overall survival among 23 children and young adults with severe aplastic ...

The 4th GANSID Congress 2026 concluded after three days of discussions on inherited blood disorders. Delegates from 23 countries examined prevention, early diagnosis, equitable healthcare access, bone ...

Even as a medical student, Dr. David Fajgenbaum took the “physician, heal thyself” adage literally. It saved his life.

Dominique Bonnet and Frederic Relaix join the Stem Cell Reports editorial team, adding expertise in hematopoietic ...

Vicksburg teenager battling a rare genetic disorder is preparing for a major step in his medical journey as he becomes ...

For patients with hairy cell leukemia whose cancer returns after multiple treatments, researchers are investigating whether ...

(NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has expanded approval of TALZENNA ® (talazoparib ...

After more than 100 hospitalizations, Phillip Mullin’s gene therapy milestone offers new hope amid longstanding racial disparities and decades of sickle cell research.

Bone disorders impact millions of people, but new research suggests quality of life could be improved by taking a natural extract from French maritime pine bark.

Research led by internist-nephrologist Dr. Michele Eisenga shows that SGLT2 inhibitors, a class of drugs widely used to treat ...

Researchers are exploring new options for patients with relapsed or refractory hairy cell leukemia, including chimeric ...